Xenon Pharmaceuticals Inc. (XENE) — Stock Score Summary

Xenon Pharmaceuticals Inc. (XENE) has a MoatMap StockRank of 43/100 based on Quality (36/100), Value (32/100), and Momentum (61/100) factor scores. The current signal is HOLD. Xenon Pharmaceuticals is a clinical-stage biotech company with no current revenues, making it a speculative bet rather than a quality compounder with a margin of safety.

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for neurological disorders, with a primary emphasis on epilepsy. The company's lead candidate, azetukalner, is a novel potassium channel opener designed to treat focal onset seizures. Xenon's competitive advantage lies in its deep expertise in ion channel biology and a robust pipeline of precision medicines.

Key Financial Metrics

Price$52.79
Market Cap$5.3B
P/E (Forward)-10.58
Price/Book7.29
Return on Equity-37.5%
Return on Invested Capital-63.1%
Debt/Equity0.56
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-186M

Xenon Pharmaceuticals Inc. operates in the Biotechnology industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Xenon Pharmaceuticals Inc.’s (XENE) StockRank?
MoatMap’s StockRank for Xenon Pharmaceuticals Inc. (XENE) is 43/100, with a Hold signal. It is a composite of Quality (36), Value (32), and Momentum (61) factor ranks across MoatMap’s 19,000+ stock universe.
Does Xenon Pharmaceuticals Inc. have an economic moat?
Xenon Pharmaceuticals Inc. (XENE) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Xenon Pharmaceuticals Inc. a buy, hold, or sell?
MoatMap’s current signal for Xenon Pharmaceuticals Inc. (XENE) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Xenon Pharmaceuticals Inc. in?
Xenon Pharmaceuticals Inc. (XENE) operates in the Healthcare sector, specifically the Biotechnology industry (Canada).
Browse all ranked stocksXENE deep dive reportAI ChampionsHow we score stocksSense-check another stock